Tom Vogwill

Tom Vogwill

Auto-generated profile, based on publicly available information

Tom Vogwill

Department of Zoology, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2010 in Nature
Verified
Journal Article
Closed access
PDF file
SPSteve Paterson
Steve Paterson
TVTom Vogwill
Tom Vogwill
ABAngus Buckling
Angus Buckling
RBRebecca Benmayor
Rebecca Benmayor
ASAndrew J Spiers
Andrew J Spiers
MBMichael A. Brockhurst
Michael A. Brockhurst

12 December 2014 in Evolutionary Applications
Verified
Journal Article
Open access
PDF file
TVTom Vogwill
Tom Vogwill
RMR. Craig MacLean
R. Craig MacLean
The evolution of antibiotic resistance carries a fitness cost, expressed in terms of reduced competitive ability in the absence of antibiotics. This cost plays a key role in the dynamics of resistance by generating selection against resistance when bacteria encounter an antibiotic‐free environment. Previous work has shown that the cost of resistance is highly variable, but the underlying causes remain poorly understood. Here, we use a meta‐analysis of the published resistance literature to determine how the genetic basis of resistance influences its cost. We find that on average chromosomal resistance mutations carry a larger cost than acquiring resistance via a plasmid. This may explain why resistance often evolves by plasmid acquisition. Second, we find that the cost of plasmid acquisition increases with the breadth of its resistance range. This suggests a potentially important limit on the evolution of extensive multidrug resistance via plasmids. We also find that epistasis can significantly alter the cost of mutational resistance. Overall, our study shows that the cost of antimicrobial resistance can be partially explained by its genetic basis. It also highlights both the danger associated with plasmidborne resistance and the need to understand why resistance plasmids carry a relatively low cost.

11 May 2016 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
TVT. Vogwill
T. Vogwill
MKM. Kojadinovic
M. Kojadinovic
RMR. C. MacLean
R. C. MacLean
Antibiotic resistance often evolves by mutations at conserved sites in essential genes, resulting in parallel molecular evolution between divergent bacterial strains and species. Whether these resistance mutations are having parallel effects on fitness across bacterial taxa, however, is unclear. This is an important point to address, because the fitness effects of resistance mutations play a key role in the spread and maintenance of resistance in pathogen populations. We address this idea by measuring the fitness effect of a collection of rifampicin resistance mutations in the β subunit of RNA polymerase (rpoB) across eight strains that span the diversity of the genusPseudomonas. We find that almost 50% ofrpoBmutations have background-dependent fitness costs, demonstrating that epistatic interactions betweenrpoBand the rest of the genome are common. Moreover, epistasis is typically strong, and it is the dominant genetic determinant of the cost of resistance mutations. To investigate the functional basis of epistasis, and becauserpoBplays a central role in transcription, we measured the effects of commonrpoBmutations on transcriptional efficiency across three strains ofPseudomonas. Transcriptional efficiency correlates strongly to fitness across strains, and epistasis arises because individualrpoBmutations have differential effects on transcriptional efficiency in different genetic backgrounds.

25 February 2013 in New Phytologist
Verified
Journal Article
Open access
PDF file
MLMato Lagator
Mato Lagator
TVTom Vogwill
Tom Vogwill
AMAndrew Mead
Andrew Mead
NCNick Colegrave
Nick Colegrave
PNPaul Neve
Paul Neve
Summary: The widespread evolution of resistance to herbicides is a pressing issue in global agriculture. Evolutionary principles and practices are key to the management of this threat to global food security. The application of mixtures of herbicides has been advocated as an anti‐resistance strategy, without substantial empirical support for its validation. We evolved experimentally populations of the unicellular green chlorophyte, Chlamydomonas reinhardtii, to minimum inhibitory concentrations (MICs) of single‐herbicide modes of action and to pair‐wise and three‐way mixtures between different herbicides at various total combined doses. Herbicide mixtures were most effective when each component was applied at or close to its MIC. When doses were high, increasing the number of mixture components was also effective in reducing the evolution of resistance. Employing mixtures at low combined doses did not retard resistance evolution, even accelerating the evolution of resistance to some components. At low doses, increasing the number of herbicides in the mixture tended to select for more generalist resistance (cross‐resistance). Our results reinforce findings from the antibiotic resistance literature and confirm that herbicide mixtures can be very effective for resistance management, but that mixtures should only be employed where the economic and environmental context permits the applications of high combined doses.

23 April 2018 in Nature Ecology & Evolution
Verified
Journal Article
Open access
PDF file
DGDanna R. Gifford
Danna R. Gifford
VFVictoria Furió
Victoria Furió
APAndrei Papkou
Andrei Papkou
TVTom Vogwill
Tom Vogwill
AOAntonio Oliver
Antonio Oliver
RMR. Craig MacLean
R. Craig MacLean
There is an urgent need to develop novel approaches for predicting and preventing the evolution of antibiotic resistance. Here, we show that the ability to evolve de novo resistance to a clinically important β-lactam antibiotic, ceftazidime, varies drastically across the genus Pseudomonas. This variation arises because strains possessing the ampR global transcriptional regulator evolve resistance at a high rate. This does not arise because of mutations in ampR. Instead, this regulator potentiates evolution by allowing mutations in conserved peptidoglycan biosynthesis genes to induce high levels of β-lactamase expression. Crucially, blocking this evolutionary pathway by co-administering ceftazidime with the β-lactamase inhibitor avibactam can be used to eliminate pathogenic P. aeruginosa populations before they can evolve resistance. In summary, our study shows that identifying potentiator genes that act as evolutionary catalysts can be used to both predict and prevent the evolution of antibiotic resistance.

21 December 2014 in Evolution, Medicine, and Public Health
Verified
Journal Article
Open access
PDF file
RMR. Craig MacLean
R. Craig MacLean
TVTom Vogwill
Tom Vogwill
Antibiotic resistance carries a fitness cost that could potentially limit the spread of resistance in bacterial pathogens. In spite of this cost, a large number of experimental evolution studies have found that resistance is stably maintained in the absence of antibiotics as a result of compensatory evolution. Clinical studies, on the other hand, have found that resistance in pathogen populations usually declines after antibiotic use is stopped, suggesting that compensatory adaptation is not effective in vivo. In this article, we argue that this disagreement arises because there are limits to compensatory adaptation in nature that are not captured by the design of current laboratory selection experiments. First, clinical treatment fails to eradicate antibiotic-sensitive strains, and competition between sensitive and resistant strains leads to the rapid loss of resistance following treatment. Second, laboratory studies overestimate the efficacy of compensatory adaptation in nature by failing to capture costs associated with compensatory mutations. Taken together, these ideas can potentially reconcile evolutionary theory with the clinical dynamics of antibiotic resistance and guide the development of strategies for containing resistance in clinical pathogens.